Sort
39,280 grants matching “leukemia”
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
$670,935Pinkal Desai · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
EXPLOITING METTL3 INHIBITION-INDUCED DYSREGULATION OF DNA REPAIR IN THE TREATMENT OF LEUKEMIA
$670,917Yale Univ · · FY2025 · Defense Health Agency
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$670,697Joshua Aiden Hill · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia
$670,671Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2014 · CA
Brain Tumors - Immunological and Biological Studies
$670,357Darell D Bigner · Duke University · R37 · FY2008 · CA
Childhood adversity, DNA methylation, and psychopathology symptoms: A longitudinal study of sensitive periods and chrono-epigenetics
$670,300Erin Cathleen Dunn · Massachusetts General Hospital · R01 · FY2022 · MH
Clinical Development of Novel Drugs for Children with Refractory Cancers
$670,118Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Multi-wavelength femtosecond laser sources for intravital multiphoton microscopy
$670,076Chris Xu · Cornell University · R01 · FY2014 · EB
Genetic and molecular basis for SRSF2 mutations in myelodysplasia
$670,015Robert K Bradley · Fred Hutchinson Cancer Research Center · R01 · FY2015 · HL
Using Aldehyde Tags to Generate Site-Specifically Modified Antibody Drug Conjugat
$669,945David Ian Rabuka · Redwood Bioscience, Inc. · R44 · FY2014 · GM
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
$669,923John Dunning Boice · Vanderbilt University · U01 · FY2012 · CA
The role of the MBD2-NuRD complex in gamma-globin gene silencing
$669,872Gordon D Ginder · Virginia Commonwealth University · R01 · FY2018 · DK
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia
$669,866Etan Orgel · Children'S Hospital Of Los Angeles · R37 · FY2023 · CA
Biochemical Mechanisms of Neural Plasticity
$669,855John David Sweatt · University Of Alabama At Birmingham · R01 · FY2015 · MH
RUNX1-mediated regulation of MEP fate specification
$669,741Diane S. Krause · Yale University · R01 · FY2024 · DK
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
$669,698Bruce R. Blazar · University Of Minnesota · R01 · FY2023 · HL
Novel CRISPR-Cas9 protein delivery to T cells in vivo by targeting CD7
$669,671Guohua Yi · University Of Texas Hlth Ctr At Tyler · UG3 · FY2021 · AI
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$669,635Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Nuclear Structure and Gene Expression
$669,529Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · CA
Variant to Function Mapping of B-ALL Risk Loci
$669,524Vijay Ganesh Sankaran · Boston Children'S Hospital · R01 · FY2025 · CA
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
$669,442Lydia B Zablotska · University Of California, San Francisco · R01 · FY2018 · CA
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
$669,389Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Functional and translational studies of RUNX1 and CBFB in hematopoiesis
$669,266Paul Liu · National Human Genome Research Institute · ZIA · FY2016 · HG
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
$669,100Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Experimental Therapeutics of Pediatric Hematopoietic Malignancies
$668,961Alan S Wayne · Clinical Sciences · Z01 · FY2007 · CA